Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. CYCLOBENZAPRINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1977
Medication labelWhy this: Advisory · dailymed-prescription
Cyclobenzaprine hydrochloride extended-release capsules are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion. Limitations of Use: • Cyclobenzaprine hydrochloride extended-release capsules should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. • Cyclobenzaprine hydrochloride extended-release capsules have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease or in children with cerebral palsy.
- generic_name
- cyclobenzaprine hydrochloride
- product_names
- Cyclobenzaprine Hydrochloride
- ndc
- 33342-272, 33342-273, 33342-272-09, 33342-272-12, 33342-273-09, 33342-273-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en